Detalles de la búsqueda
1.
Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma.
Oncologist
; 29(3): 213-218, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070191
2.
Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy.
Oncologist
; 24(3): 313-318, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30139836
3.
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer.
Oncotarget
; 15: 238-247, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38502947
4.
Bone-Targeted Therapy Regimen and Skeletal-Related Events in Patients Surviving Longer Than 2 Years With Metastatic Breast Cancer and Bone Metastasis.
Clin Breast Cancer
; 23(8): e515-e522, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37735019
5.
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
Res Sq
; 2023 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36824840
6.
Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma.
Eur J Cancer
; 191: 113250, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37573674
7.
Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies.
NPJ Breast Cancer
; 8(1): 131, 2022 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36539444
8.
Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer.
NPJ Breast Cancer
; 8(1): 46, 2022 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35393462
9.
Targeting Metabolic Adaptations in the Breast Cancer-Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy.
Mol Cancer Res
; 20(6): 923-937, 2022 06 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35259269
10.
T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab.
J Clin Oncol
; 34(29): 3511-3517, 2016 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27298406
Resultados
1 -
10
de 10
1
Próxima >
>>